Skip to main content
CLNN
NASDAQ Life Sciences

Former Board Member Files to Sell Additional $335K in Clene Inc. Shares, Continuing Distribution Trend

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
7
Price
$5.85
Mkt Cap
$68.903M
52W Low
$2.28
52W High
$13.5
Market data snapshot near publication time

summarizeSummary

A former board member of Clene Inc. has filed a Form 144 indicating intent to sell an additional $335,804 worth of common stock, extending a recent pattern of insider share distribution amidst the company's going concern warning.


check_boxKey Events

  • Intent to Sell Additional Shares

    Symbiosis II LLC, a former board member, filed a Form 144 to sell 56,916 shares of Clene Inc. common stock, valued at approximately $335,804.00.

  • Continuation of Insider Distribution

    This filing extends a recent pattern of significant insider selling, with Symbiosis II LLC having already sold 291,980 shares for gross proceeds of $1,560,394.90 in the past three months.

  • Context of Financial Uncertainty

    The ongoing insider sales occur against the backdrop of Clene Inc.'s last annual report (2026-03-17), which raised substantial doubt about the company's ability to continue as a going concern.


auto_awesomeAnalysis

This Form 144 filing indicates a continued intent by a former board member, Symbiosis II LLC, to liquidate a significant portion of their holdings in Clene Inc. The proposed sale of over $335,000 worth of shares, following nearly $1.6 million in sales over the past three months, reinforces a clear pattern of insider distribution. This ongoing selling pressure from a key insider is particularly notable given the company's recent disclosure of substantial doubt about its ability to continue as a going concern, as highlighted in its last annual report. Investors should view this as a negative signal regarding insider confidence and potential future stock overhang.

At the time of this filing, CLNN was trading at $5.85 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $68.9M. The 52-week trading range was $2.28 to $13.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CLNN - Latest Insights

CLNN
Apr 28, 2026, 4:10 PM EDT
Filing Type: 144
Importance Score:
7
CLNN
Apr 22, 2026, 5:55 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Apr 17, 2026, 8:17 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Apr 15, 2026, 4:05 PM EDT
Filing Type: 144
Importance Score:
8
CLNN
Apr 10, 2026, 4:06 PM EDT
Filing Type: DEFA14A
Importance Score:
8
CLNN
Apr 10, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CLNN
Mar 31, 2026, 5:05 PM EDT
Filing Type: 144
Importance Score:
7
CLNN
Mar 31, 2026, 4:35 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Mar 24, 2026, 4:36 PM EDT
Filing Type: 144
Importance Score:
8
CLNN
Mar 17, 2026, 7:00 AM EDT
Filing Type: 10-K
Importance Score:
9